newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces Pricing of $4 Million Public Offering

MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for hospital and related settings, today